Literature DB >> 29089180

Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee.

Richard L Gallo1, Richard D Granstein2, Sewon Kang3, Mark Mannis4, Martin Steinhoff5, Jerry Tan6, Diane Thiboutot7.   

Abstract

In 2002, the National Rosacea Society assembled an expert committee to develop the first standard classification of rosacea. This original classification was intended to be updated as scientific knowledge and clinical experience increased. Over the last 15 years, significant new insights into rosacea's pathogenesis and pathophysiology have emerged, and the disorder is now widely addressed in clinical practice. Growing knowledge of rosacea's pathophysiology has established that a consistent multivariate disease process underlies the various clinical manifestations of this disorder, and the clinical significance of each of these elements is increasing as more is understood. This review proposes an updated standard classification of rosacea that is based on phenotypes linked to our increased understanding of disease pathophysiology. This updated classification is intended to provide clearer parameters to conduct investigations, guide diagnosis, and improve treatment.
Copyright © 2017 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  comorbidity; erythema; ocular; papules; pathophysiology; phenotypes; phymas; pustules; rosacea; telangiectasia

Mesh:

Year:  2017        PMID: 29089180     DOI: 10.1016/j.jaad.2017.08.037

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  53 in total

Review 1.  A Review of Management Strategies for Nociceptive and Neuropathic Ocular Surface Pain.

Authors:  Harrison Dermer; Daniella Lent-Schochet; Despoina Theotoka; Christian Paba; Abdullah A Cheema; Ryan S Kim; Anat Galor
Journal:  Drugs       Date:  2020-04       Impact factor: 9.546

2.  Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS).

Authors:  James Q Del Rosso; Emil Tanghetti; Guy Webster; Linda Stein Gold; Diane Thiboutot; Richard L Gallo
Journal:  J Clin Aesthet Dermatol       Date:  2020-06-01

3.  Botulinum toxin blocks mast cells and prevents rosacea like inflammation.

Authors:  Jae Eun Choi; Tyler Werbel; Zhenping Wang; Chia Chi Wu; Tony L Yaksh; Anna Di Nardo
Journal:  J Dermatol Sci       Date:  2018-12-28       Impact factor: 4.563

4.  Minocycline Extended-Release Comparison with Doxycycline for the Treatment of Rosacea: A Randomized, Head-to-Head, Clinical Trial.

Authors:  Athanasios Tsianakas; Thomas Pieber; Hilary Baldwin; Franz Feichtner; Shanavas Alikunju; Anirudh Gautam; Srinivas Shenoy; Preeti Singh; Srinivas Sidgiddi
Journal:  J Clin Aesthet Dermatol       Date:  2021-12

5.  Biophotonic Therapy with Fluorescent Light Energy Decreases Facial Erythema, Improves Signs and Symptoms of Rosacea, and Increases Patient Satisfaction: A Postmarket Study.

Authors:  Martin Wade; Vanessa Charest; Bruno Ballardin; Deirdre Edge; Michael Canova Engelbrecht Nielsen
Journal:  J Clin Aesthet Dermatol       Date:  2021-07-01

6.  [Corneal alterations in eyelid diseases].

Authors:  Elisabeth M Messmer
Journal:  Ophthalmologe       Date:  2020-09       Impact factor: 1.059

Review 7.  Cutaneous and ocular rosacea: Common and specific physiopathogenic mechanisms and study models.

Authors:  Daniela Rodrigues-Braz; Min Zhao; Nilufer Yesilirmak; Selim Aractingi; Francine Behar-Cohen; Jean-Louis Bourges
Journal:  Mol Vis       Date:  2021-05-13       Impact factor: 2.367

8.  Rosacea: New Concepts in Classification and Treatment.

Authors:  Esther J van Zuuren; Bernd W M Arents; Mireille M D van der Linden; Sofieke Vermeulen; Zbys Fedorowicz; Jerry Tan
Journal:  Am J Clin Dermatol       Date:  2021-03-23       Impact factor: 7.403

9.  Prevalence and Risk Factors of Anxiety and Depression in Rosacea Patients: A Cross-Sectional Study in China.

Authors:  Mengting Chen; Zhili Deng; Yingxue Huang; Ji Li
Journal:  Front Psychiatry       Date:  2021-06-16       Impact factor: 4.157

10.  Lupus Miliaris Disseminatus Faciei versus Granulomatous Rosacea: A Case Report.

Authors:  Ji-In Seo; Min Kyung Shin
Journal:  Case Rep Dermatol       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.